 |
PDBsum entry 4o6t
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Heme binding protein
|
PDB id
|
|
|
|
4o6t
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Heme binding protein
|
 |
|
Title:
|
 |
1.25a resolution structure of the hemophore hasa from pseudomonas aeruginosa (h83a mutant, ph 5.4)
|
|
Structure:
|
 |
Hasap. Chain: a. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Pseudomonas aeruginosa. Organism_taxid: 287. Gene: hasap. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Resolution:
|
 |
|
1.25Å
|
R-factor:
|
0.154
|
R-free:
|
0.182
|
|
|
Authors:
|
 |
S.Lovell,R.Kumar,K.P.Battaile,H.Matsumura,H.Yao,J.C.Rodriguez, P.Moenne-Loccoz,M.Rivera
|
|
Key ref:
|
 |
R.Kumar
et al.
(2014).
Replacing the axial ligand tyrosine 75 or its hydrogen bond partner histidine 83 minimally affects hemin acquisition by the hemophore HasAp from Pseudomonas aeruginosa.
Biochemistry,
53,
2112-2125.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
23-Dec-13
|
Release date:
|
26-Mar-14
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
O69756
(O69756_PSEAI) -
HasAp from Pseudomonas aeruginosa
|
|
|
|
Seq: Struc:
|
 |
 |
 |
205 a.a.
182 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Biochemistry
53:2112-2125
(2014)
|
|
PubMed id:
|
|
|
|
|
| |
|
Replacing the axial ligand tyrosine 75 or its hydrogen bond partner histidine 83 minimally affects hemin acquisition by the hemophore HasAp from Pseudomonas aeruginosa.
|
|
R.Kumar,
H.Matsumura,
S.Lovell,
H.Yao,
J.C.Rodríguez,
K.P.Battaile,
P.Moënne-Loccoz,
M.Rivera.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Hemophores from Pseudomonas aeruginosa (HasAp), Serratia marcescens (HasAsm),
and Yersinia pestis (HasAyp) bind hemin between two loops. One of the loops
harbors conserved axial ligand Tyr75 (Y75 loop) in all three structures, whereas
the second loop (H32 loop) contains axial ligand His32 in HasAp and HasAsm, but
a noncoordinating Gln32 in HasAyp. Binding of hemin to the Y75 loop of HasAp or
HasAsm causes a large rearrangement of the H32 loop that allows His32
coordination. The Q32 loop in apo-HasAyp is already in the closed conformation,
such that binding of hemin to the conserved Y75 loop occurs with minimal
structural rearrangement and without coordinative interaction with the Q32 loop.
In this study, structural and spectroscopic investigations of the hemophore
HasAp were conducted to probe (i) the role of the conserved Tyr75 loop in hemin
binding and (ii) the proposed requirement of the His83-Tyr75 hydrogen bond to
allow the coordination of hemin by Tyr75. High-resolution crystal structures of
H83A holo-HasAp obtained at pH 6.5 (0.89 Å) and pH 5.4 (1.25 Å) show that
Tyr75 remains coordinated to the heme iron, and that a water molecule can
substitute for Nδ of His83 to interact with the Oη atom of Tyr75, likely
stabilizing the Tyr75-Fe interaction. Nuclear magnetic resonance spectroscopy
revealed that in apo-Y75A and apo-H83A HasAp, the Y75 loop is disordered, and
that disorder propagates to nearby elements of secondary structure, suggesting
that His83 Nδ-Tyr75 Oη interaction is important to the organization of the Y75
loop in apo-HasA. Kinetic analysis of hemin loading conducted via stopped-flow
UV-vis and rapid-freeze-quench resonance Raman shows that both mutants load
hemin with biphasic kinetic parameters that are not significantly dissimilar
from those previously observed for wild-type HasAp. When the structural and
kinetic data are taken together, a tentative model emerges, which suggests that
HasA hemophores utilize hydrophobic, π-π stacking, and van der Waals
interactions to load hemin efficiently, while axial ligation likely functions to
slow hemin release, thus allowing the hemophore to meet the challenge of
capturing hemin under inhospitable conditions and delivering it selectively to
its cognate receptor.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |